Showing 811-820 of 5314 results for "".
Valeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Otezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for pSpend Wisely on Marketing
https://practicaldermatology.com/topics/practice-management/spend-wisely-on-marketing/19061/The best investment in marketing focuses on a long-range plan. If you have good ideas without a firm strategy and follow-through, your investment won't pay off, says Tracy Drumm, Vice President of IF Marketing.Rosacea: The Patient's Perspective
https://practicaldermatology.com/topics/practice-management/rosacea-the-patient-s-perspective/19263/Flor Mayoral, MD addresses the impact of rosacea on patients and offers strategies to encourage adherence. Dr. Mayoral participated in the "Face to Face with Rosacea: Empowering Professionals and Patients" event featuring actress Cynthia Nixon and supported by the National Rosacea Society and GalderJoel Schlessinger MD Discusses Electronic Medical Records
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-discusses-electronic-medical-records/19281/Joel Schlessinger MD continues to incorporate new technologies and techniques into his growing dermatology and cosmetic surgery practice at Skin Specialists P.C. To keep up with technology growth in the medical field, Joel Schlessinger MD recently integrated the use of electronic medical records (EMCosmeceutical Science
https://practicaldermatology.com/topics/general-topics/cosmeceutical-science/19293/Patti Farris, MD discusses recent developments in cosmeceutical formulation with an emphasis on the latest research on ingredients like botanicals, growth factors, and peptides. She reviews the best evidence for cosmeceuticals and offers tips on product selection and use in a conversation with hostDr. Joel Schlessinger's Tips for Hiring
https://practicaldermatology.com/topics/practice-management/dr-joel-schlessinger-39-s-tips-for-hiring/19295/In this video, Dr. Joel Schlessinger offers his advice for hiring employees. When finding new staff for his own practice, Dr. Joel Schlessinger makes sure each employee is a great fit for his organization. He puts each candidate through a test to find out if he or she is detail oriented, makes a poiEducating NPs and PAs
https://reachmd.com/programs/practical-dermatology/educating-nps-and-pas/39884/Jennifer Cather, MD, and Melodie Young ASN, RN, discuss recent consensus statements from the Genital Psoriasis Wellness Consortium, and Scott Boswell, MD, joins Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss his boot camp for nurse practitioners and phyWhat's New in Atopic Dermatitis?
https://reachmd.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.In-Depth From the Science of Skincare Summit
https://practicaldermatology.com/issues/january-february-2025/in-depth-from-the-science-of-skincare-summit/32979/The 2024 Science of Skincare Summit this past November again positioned itself as a pivotal event in the dermatology field, offering groundbreaking insights into the intersection of innovation, consumer trends, and evidence-based skincare. Take a closer look at some of the research.